PSMA-targeted 18F-labeled Radiohybrid Inhibitors: Labeling chemistry and automated GMP production of 18F-rhPSMA-7

被引：0
|
作者：
Wurzer, Alexander [2 ]
Di Carlo, Daniel [2 ]
Schmidt, Alexander [2 ]
Beck, Roswitha [2 ]
Schwaiger, Markus [1 ]
Herz, Michael [1 ]
Eiber, Matthias [1 ]
Wester, Hans [2 ]
机构：
[1] Klinikum Rechts Der Isar, Munich, Germany
[2] Tech Univ Munich, Pharmaceut Radiochem, Garching, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
342
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, 18F-rhPSMA-7, in Patients with Prostate Cancer
    Oh, So Won
    Wurzer, Alexander
    Teoh, Eugene J.
    Oh, Sohee
    Langbein, Thomas
    Kroenke, Markus
    Herz, Michael
    Kropf, Saskia
    Wester, Hans-Juergen
    Weber, Wolfgang A.
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (05) : 702 - 709
  • [2] 18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging
    Werner, Rudolf A.
    Derlin, Thorsten
    Lapa, Constantin
    Sheikbahaei, Sara
    Higuchi, Takahiro
    Giesel, Frederik L.
    Behr, Spencer
    Drzezga, Alexander
    Kimura, Hiroyuki
    Buck, Andreas K.
    Bengel, Frank M.
    Pomper, Martin G.
    Gorin, Michael A.
    Rowe, Steven P.
    THERANOSTICS, 2020, 10 (01): : 1 - 16
  • [3] Automated Production of 18F-labeled Acyl Fluorides as 18F-fluorination Synthons
    DeGrado, Timothy R.
    Nathan, Gregory
    Jiang, Huailei
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S200 - S200
  • [4] Preclinical biodistribution and dosimetry and human biodistribution comparing 18F-rhPSMA-7 and single isomer 18F-rhPSMA-7.3
    Knorr, Karina
    Oh, So Won
    Kroenke, Markus
    Wurzer, Alexander
    D'Alessandria, Calogero
    Herz, Michael
    Weber, Wolfgang
    Wester, Hans-Jurgen
    Eiber, Matthias
    Yusufi, Nahid
    Nekolla, Stephan
    EJNMMI RESEARCH, 2022, 12 (01)
  • [5] Preclinical biodistribution and dosimetry and human biodistribution comparing 18F-rhPSMA-7 and single isomer 18F-rhPSMA-7.3
    Karina Knorr
    So Won Oh
    Markus Krönke
    Alexander Wurzer
    Calogero D’Alessandria
    Michael Herz
    Wolfgang Weber
    Hans-Jürgen Wester
    Matthias Eiber
    Nahid Yusufi
    Stephan Nekolla
    EJNMMI Research, 12
  • [6] Comparison of [18F]PSMA-1007 with Novel 18F-Labeled PSMA Inhibitor
    Donat, Cornelius
    Craig, Austin
    Kogler, Juergen
    Laube, Markus
    Kopka, Klaus
    Stadlbauer, Sven
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S75 - S76
  • [7] First-in-man analysis of [18F]DCFPyL, a second generation, 18F-labeled PSMA-targeted radiotracer, in patients with metastatic prostate cancer
    Mena, Esther
    Szabo, Zsolt
    Rowe, Steven
    Antonarakis, Emmanuel
    Eisenberger, Mario
    Carducci, Michael
    Vranesic, Melin
    Mease, Ronnie
    Cho, Steve
    Pomper, Martin
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [8] A high affinity 18F-labeled phosphoramidate peptidomimetic inhibitor as a PSMA-targeted PET imaging agent for prostate cancer
    Ganguly, Tanushree
    Dannoon, Shorouk
    Geruntho, Jonathan G.
    Hopkins, Mark R.
    Murphy, Stephanie Murphy
    Cahaya, Hendry
    Blecha, Joseph E.
    Jivan, Salma
    Cyril, Barinka
    Jones, Ella F.
    VanBrocklin, Henry F.
    Berkman, Clifford E.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S379 - S379
  • [9] Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors
    Wurzer, Alexander
    Di Carlo, Daniel
    Schmidt, Alexander
    Beck, Roswitha
    Eiber, Matthias
    Schwaiger, Markus
    Wester, Hans-Juergen
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (05) : 735 - 742
  • [10] PSMA-targeted18F-labeled Radiohybrid Inhibitors: Concept, preclinical evaluation and first proof of concept study in men
    Wurzer, Alexander
    Di Carlo, Daniel
    Schmidt, Alexander
    Beck, Roswitha
    Eiber, Matthias
    Schwaiger, Markus
    Wester, Hans
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12345